TX-TECH-MAHINDRA
22.2.2021 14:31:07 CET | Business Wire | Press release
Tech Mahindra Ltd., one of the fastest growing Global IT companies and a leading provider of digital transformation, consulting and business re-engineering services and solutions, today announced the launch of a first-of-its-kind phygital (physical and digital) Global Chess League. It also announced that Viswanathan Anand, five-time World Chess Champion, and Indian Chess Grandmaster will mentor, partner, advise and help shape the league. With his motivational and inspirational stature across the world as an individual and a chess champion, Anand will help catalyse the growth of chess, further building the sport that has defined his entire life as he joins hands with the Tech Mahindra Global Chess League and becomes its face for the global audience and his fans.
The League’s launch will mark a watershed moment as it aims to raise the profile of the sport, discover new generations of chess champions, enhance the fan base of the sport and take the sport to new commercial heights. New-age technologies such as 5G, artificial intelligence, and virtual reality will be at the core and will be leveraged to explore innovative ways of promoting the game through interactive platforms to engage a global audience. Tech Mahindra will act as the architect behind this concept and will provide necessary operational and technological support to execute the vision.
Anand Mahindra, Chairman, Mahindra Group, said, “Chess still has an incipient and largely untapped potential across the globe. Recently, there has been a surge of interest post the online Chess Olympiad and the enormous popularity of a TV series based on the game. We hope that the creation of a league will harness this resurgence of interest and bring about a renaissance in the world of chess. I am particularly excited about sharing my learnings from founding the Pro Kabaddi league with the team in order to replicate that success on a much larger and global platform.”
Viswanathan Anand, 5-time World Chess Champion, said , “Chess is a game that is played by millions around the world. At this time, a unique opportunity exists to popularize it further and dramatically enhance its visibility through a global league powered by technology. I am personally happy to partner with a technology provider like Tech Mahindra, whose endorsement and promotion will certainly elevate the sport to a higher level and offer the right platform to popularize chess across the globe. There is a renewed interest in the game of chess and through this unique global league format, we will be able to keep the spirit of chess intact and ensure the right platform is provided to upcoming talent.”
Current plans envision the League to engage players from all levels – professional or otherwise. The League will have 8 franchise owned teams from across the world. The teams will comprise of a mix of titled women and men players along with juniors and wildcard entrants playing each other in a Round Robin format. The teams qualifying for the semifinals will enter the knockout stage of the championship. We are actively looking at the prospect of introducing innovative scoring, board selection methods and a fantasy league to maximize viewer engagement. The final League structure and team details will be announced in due course.
CP Gurnani, MD & CEO, Tech Mahindra, said, “Chess has many synergies with the business world, with its emphasis on intellect, strategy and mental rigor. By leveraging Tech Mahindra’s expertise in new age technologies like 5G and Virtual Reality to drive fan engagement and viewership globally, we can truly transform chess into an e-sport. Furthermore, this global chess league will help us create an exceptional and inspirational experience by bringing the game home to global fans.”
As part of its NXT.NOW framework, which aims to enhance ‘Human Centric Experience’, Tech Mahindra has a deep focus on leveraging cutting-edge technologies to deliver enhanced experience and enable digital transformation to meet the evolving needs of the customer.
About Viswanathan Anand
As a five-time World Chess Champion, Viswanathan Anand has cemented his place among the greatest Champions of all times. His hallmark lightning speed and intuitive play is well recognized and critics rate him as one of the biggest natural talents ever in the history of chess. He is the only champion in chess history to have won a World championship title in all formats, match, knock-out and tournament. In India he has received the high civilian awards of Padma Vibhushan, Padma Bhushan, Padma Shri and Arjuna Award. He is also the first recipient of the Rajiv Gandhi Khel Ratna Award. He is also a six-time winner of the coveted “Chess Oscars.”
About Tech Mahindra
Tech Mahindra offers innovative and customer-centric digital experiences, enabling enterprises, associates and the society to Rise. We are a USD 5.2 billion organization with 121,900+ professionals across 90 countries helping 997 global customers, including Fortune 500 companies. We are focused on leveraging next-generation technologies including 5G, Blockchain, Cybersecurity, Artificial Intelligence, and more, to enable end-to-end digital transformation for global customers. Tech Mahindra is one of the fastest growing brands and amongst the top 15 IT service providers globally. Tech Mahindra has consistently emerged as a leader in sustainability and is recognized amongst the ‘2021 Global 100 Most sustainable corporations in the World’ by Corporate Knights. With the NXT.NOW framework, Tech Mahindra aims to enhance ‘Human Centric Experience’ for our ecosystem and drive collaborative disruption with synergies arising from a robust portfolio of companies. We aim at delivering tomorrow’s experiences today, and believe that the ‘Future is Now’.
We are part of the Mahindra Group, a USD 19.4 billion federation of companies that enables people to rise through innovative mobility solutions, driving rural prosperity, enhancing urban living, nurturing new businesses and fostering communities. It enjoys a leadership position in utility vehicles, information technology, financial services and vacation ownership in India and is the world’s largest tractor company by volume. It also enjoys a strong presence in renewable energy, agribusiness, logistics and real estate development. Headquartered in India, Mahindra employs over 2, 56,000 people across 100 countries.
Connect with us on www.techmahindra.com
Our Social Media Channels
Facebook: https://www.facebook.com/TechMahindra
Twitter: https://twitter.com/Tech_Mahindra
LinkedIn: https://www.linkedin.com/company/tech-mahindra/
YouTube: https://www.youtube.com/user/techmahindra09
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005512/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom